AbbVie Inc. (NYSE:ABBV) Is Largely Controlled by Institutional Shareholders Who Own 73% of the Company

Yahoo FinanceJan 4 19:00

AbbVie Hits 4-week High

Trading EconomicsJan 3 23:40

Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Zacks Jan 3 21:05

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

BenzingaJan 3 20:39

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $224

Futu NewsJan 3 19:32 · Ratings

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

abbvieJan 3 13:00